Lucid Diagnostics Inc.

LUCD · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus
108
SEC Filings

Business Summary

Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company focused on detecting esophageal precancer and cancer in patients with gastroesophageal reflux disease (GERD). Its flagship product, the EsoGuard Esophageal DNA Test, is performed on samples collected with the EsoCheck Esophageal Cell Collection Device. EsoGuard is a bisulfite-converted targeted next-generation sequencing DNA assay quantifying methylation at 31 sites on VIM and CCNA1 genes. The company operates Lucid Test Centers, satellite test center programs, and mobile testing units across the U.S.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionLUCDdiscussed_in_filing Cybersecurity
topic_mentionLUCDdiscussed_in_filing Trusted Computing
topic_mentionLUCDdiscussed_in_filing Blockchain & Crypto
topic_mentionLUCDdiscussed_in_filing Regulation
topic_mentionLUCDdiscussed_in_filing Healthcare & Bio
topic_mentionLUCDdiscussed_in_filing Cybersecurity
topic_mentionLUCDdiscussed_in_filing Trusted Computing
topic_mentionLUCDdiscussed_in_filing Blockchain & Crypto
topic_mentionLUCDdiscussed_in_filing Regulation
topic_mentionLUCDdiscussed_in_filing Healthcare & Bio
topic_mentionLUCDdiscussed_in_filing Cybersecurity
topic_mentionLUCDdiscussed_in_filing Trusted Computing
topic_mentionLUCDdiscussed_in_filing Blockchain & Crypto
topic_mentionLUCDdiscussed_in_filing Regulation
topic_mentionLUCDdiscussed_in_filing Healthcare & Bio
topic_mentionLUCDdiscussed_in_filing Cybersecurity
topic_mentionLUCDdiscussed_in_filing Trusted Computing
topic_mentionLUCDdiscussed_in_filing Blockchain & Crypto
topic_mentionLUCDdiscussed_in_filing Regulation
topic_mentionLUCDdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001437749-26-009805EDGAR73K words
2025-03-242024-12-310001641172-25-000205EDGAR—
2024-03-252023-12-310001493152-24-011161EDGAR—
2023-03-142022-12-310001493152-23-007482EDGAR—
2022-04-062021-12-310001493152-22-009199EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001493152-25-021737EDGAR23K words
2025-08-122025-06-300001493152-25-011862EDGAR—
2025-05-132025-03-310001641172-25-009986EDGAR—
2024-11-122024-09-300001493152-24-044799EDGAR—
2024-08-122024-06-300001493152-24-031168EDGAR—
2024-05-132024-03-310001493152-24-018800EDGAR—
2023-11-132023-09-300001493152-23-040623EDGAR—
2023-08-142023-06-300001493152-23-028577EDGAR—
2023-05-152023-03-310001493152-23-017413EDGAR—
2022-11-142022-09-300001493152-22-032029EDGAR—
2022-08-152022-06-300001493152-22-023043EDGAR—
2022-05-162022-03-310001493152-22-013957EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001493152-26-012807EDGAR3K words
2025-11-120001493152-25-021748EDGAR—
2025-09-250001493152-25-014872EDGAR—
2025-09-110001493152-25-013046EDGAR—
2025-09-100001493152-25-012962EDGAR—
2025-08-130001493152-25-011882EDGAR—
2025-06-180001641172-25-015613EDGAR—
2025-05-300001641172-25-013059EDGAR—
2025-05-140001641172-25-010101EDGAR—
2025-04-250001641172-25-006239EDGAR—

108 total filings indexed. 81 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC AEMD — AETHLON MEDICAL INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc.

Tags

esophageal-cancer-diagnostics gastroesophageal-reflux-disease-(gerd)-screening cancer-prevention-diagnostics primary-care-and-gastroenterology-physician-market fda-510(k)-clearance ce-mark-certification clia-certified-laboratory next-generation-sequencing-(ngs) bisulfite-conversion-dna-assay

Company Identity

CIK0001799011
TickerLUCD
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fdb1621b0719772e029957c57b5817630f55ea8a1488f51759726a3f0db6e288
parent: c972f674183d4416c3462b35184843829ff6c8d53a2a339b9c18ea3495a944c5
content hash: 157afc38c5d5a218bab70507659c79a8f802e896a13a5ec4c31c8f8f03626417
signed: 2026-04-13T04:46:07.376Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf